$SPHRY #OTCQX International Starpharma Holdings Ltd. (SPHRY: OTCQX International) | US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma’s phase 2 clinical-stage cancer treatments
Copyright 2021 – OTC Markets Group Inc.

News Link